盐酸雷莫司琼,CAS 登记号 132907-72-3,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于有机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
有机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 盐酸雷莫司琼 的 CAS 号:132907-72-3,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Ramosetron Hydrochloride · CAS 132907-72-3 · C17H18ClN3O. UNII 9551LHD87E.
| CAS Registry Number | 132907-72-3 |
|---|---|
| PubChem CID | 107999 |
| Molecular formula | C17H18ClN3O |
| IUPAC name | (1-methylindol-3-yl)-[(5R)-4,5,6,7-tetrahydro-3H-benzimidazol-5-yl]methanone;hydrochloride |
| UNII (FDA) | 9551LHD87E |
| Molecular Weight | 315.8 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 2 |
| Exact Mass | 315.1138399 |
| Monoisotopic Mass | 315.1138399 |
| Topological Polar Surface Area | 50.7 |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 413 |
| Reported hazard statements | H302 (100%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Ramosetron hydrochloride; 132907-72-3; Irribow; Nasea; YM060; YM-060; YM 060; DTXSID3021223; (R)-(-)-Ramosetron Hydrochloride; 9551LHD87E; DTXCID301223; (R)-5-((1-Methyl-3-indolyl)carbonyl)-4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride; Methanone, (1-methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzimidazol-5-yl)-, monohydrochloride, (R)-; RefChem:178616; Ramosetron HCl; (R)-(1-Methyl-1H-indol-3-yl)(4,5,6,7-tetrahydro-1H-benzo[d]imidazol-6-yl)methanone hydrochloride
CAS 132907-72-3; molecular formula C17H18ClN3O; molecular weight — g/mol.
Ramosetron hydrochloride, 132907-72-3, Irribow, Nasea, YM060, YM-060.
Hazard statements reported: H302.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.